Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Tatsuo Masubuchi"'
Autor:
Yukiomi Kushihashi, Tatsuo Masubuchi, Isaku Okamoto, Chihiro Fushimi, Morio Yamazaki, Hisashi Asano, Reo Aoki, Shota Fujii, Yukiko Asako, Yuichiro Tada
Publikováno v:
Case Reports in Oncology, Vol 17, Iss 1, Pp 471-476 (2024)
Introduction: Photoimmunotherapy (PIT) is a treatment wherein intravenous cetuximab sarotalocan sodium is administered followed by laser light irradiation. This treatment exhibits a specific antitumor effect if in tumors expressing the epidermal grow
Externí odkaz:
https://doaj.org/article/47ece69ba8be487dbda8ad1ae451692f
Autor:
Takashi Matsuki, Kouki Miura, Yuichiro Tada, Tatsuo Masubuchi, Chihiro Fushimi, Yoshihiro Nitta, Shinetsu Kamata, Isaku Okamoto, Shunsuke Miyamoto, Taku Yamashita
Publikováno v:
Otolaryngology Case Reports, Vol 13, Iss , Pp - (2019)
Background: Occupied lesions arising in the parapharyngeal space (PPS) are rare. Among these, venous malformations are particularly rare, and very few case reports have appeared. Methods: Two patients with venous malformations in the PPS were operate
Externí odkaz:
https://doaj.org/article/ea29710efa4d4ae194982c790ea0006c
Autor:
Chihiro Matsui, MD, Orgun Doruk, MD, Takakuni Tanaka, DDS, Chihiro Fushimi, DDS, Tatsuo Masubuchi, MD, PhD, Kouki Miura, MD, PhD, Hiroshi Mizuno, MD, PhD
Publikováno v:
Plastic and Reconstructive Surgery, Global Open, Vol 6, Iss 9S, Pp 11-12 (2018)
Externí odkaz:
https://doaj.org/article/b01045a95cb34e08a54fd0f1af089ef0
Autor:
TAKURO OKADA, CHIHIRO FUSHIMI, TAKASHI MATSUKI, KUNIHIKO TOKASHIKI, HIDEAKI TAKAHASHI, ISAKU OKAMOTO, HIROKI SATO, TAKAHITO KONDO, KENJI HANYU, TAKUMA KISHIDA, TATSUYA ITO, GAI YAMASHITA, TATSUO MASUBUCHI, YUICHIRO TADA, KOKI MIURA, GO OMURA, TAKU YAMASHITA, NOBUHIKO ORIDATE, KIYOAKI TSUKAHARA
Publikováno v:
Anticancer Research. 43:2717-2724
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c51a71d153e2a5a6bd0991ba6fe9d92b
https://doi.org/10.21873/anticanres.16438
https://doi.org/10.21873/anticanres.16438
Autor:
TAKASHI MATSUKI, CHIHIRO FUSHIMI, SHUNSUKE MIYAMOTO, HIDEAKI TAKAHASHI, TATSUO MASUBUCHI, YUICHIRO TADA, KOUKI MIURA, SHIN-ETSU KAMATA, KOICHI KANO, SHOHEI TSUTSUMI, KAHO MOMIYAMA, TAKU YAMASHITA
Publikováno v:
Anticancer Research. 42:3177-3183
In patients with squamous cell carcinoma of the head and neck (SCCHN), delayed surgery can result in poorer postoperative function and prognosis due to the growth of the tumor and extended surgery. Further, delay may even make the tumor unresectable.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4315e2a85179de34fff2862b18131c2c
https://doi.org/10.21873/anticanres.15807
https://doi.org/10.21873/anticanres.15807
Autor:
TAKURO OKADA, CHIHIRO FUSHIMI, TAKASHI MATSUKI, ISAKU OKAMOTO, HIROKI SATO, TAKAHITO KONDO, KUNIHIKO TOKASHIKI, TAKUMA KISHIDA, TATSUYA ITO, GAI YAMASHITA, YUSUKE AIHARA, KENJI HANYU, YUKIOMI KUSHIHASHI, TATSUO MASUBUCHI, YUICHIRO TADA, KOUKI MIURA, YUKI HARADA, KAHO MOMIYAMA, TAKU YAMASHITA, GO OMURA, HIDEAKI TAKAHASHI, NOBUHIKO ORIDATE, KIYOAKI TSUKAHARA
Publikováno v:
Anticancer Research. 42:1607-1613
There are no real-world comparative data of nivolumab doses of 3 mg/kg and 240 mg/body for recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN). We investigated the efficacy and safety of nivolumab in treating recurrent/metas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be423a1d812728e74383ab8b5337273d
https://doi.org/10.21873/anticanres.15635
https://doi.org/10.21873/anticanres.15635
Autor:
Chihiro Fushimi, Yuichiro Tada, Tatsuo Masubuchi, Morio Yamazaki, Kenji Hanyu, Naruhisa Tanaka, Yukiomi Kushihashi, Mayu Yamauchi, Satomi Sugiyama, Kouki Miura
Publikováno v:
Toukeibu Gan. 48:14-20
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2a70b4fd724ff1e4cf874a07c7fddef4
https://doi.org/10.5981/jjhnc.48.14
https://doi.org/10.5981/jjhnc.48.14
Autor:
Yukiomi Kushihashi, Chihiro Fushimi, Tatsuo Masubuchi, Kenji Hanyu, Yuichiro Tada, Koki Miura
Publikováno v:
JOURNAL OF JAPAN SOCIETY FOR HEAD AND NECK SURGERY. 32:1-7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::69180a2ff11ce20ded28776f01def3cf
https://doi.org/10.5106/jjshns.32.1
https://doi.org/10.5106/jjshns.32.1
Autor:
Yukiomi Kushihashi, Tatsuo Masubuchi, Isaku Okamoto, Chihiro Fushimi, Kenji Hanyu, Mayu Yamauchi, Yuichiro Tada, Koki Miura
Publikováno v:
International Journal of Otolaryngology and Head & Neck Surgery. 11:258-265
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::49662be45a9533818d39bee40bb9daef
https://doi.org/10.4236/ijohns.2022.115027
https://doi.org/10.4236/ijohns.2022.115027
Autor:
TAKURO OKADA, TAKASHI MATSUKI, CHIHIRO FUSHIMI, ISAKU OKAMOTO, HIROKI SATO, TAKAHITO KONDO, KUNIHIKO TOKASHIKI, TATSUYA ITO, TATSUO MASUBUCHI, YUICHIRO TADA, KOUKI MIURA, KENJI HANYU, GO OMURA, HIDEKI TAKAHASHI, TAKU YAMASHITA, NOBUHIKO ORIDATE, KIYOAKI TSUKAHARA
Publikováno v:
Anticancer research. 42(10)
Nivolumab has antitumor efficacy in patients with recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) who relapse within 6 months after platinum-based therapy; however, the efficacy of nivolumab for platinum-sensitive R/M HNSCC has
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::333752f6871449e3207fb0d28370efd2
https://pubmed.ncbi.nlm.nih.gov/36192003
https://pubmed.ncbi.nlm.nih.gov/36192003